AstraZeneca (NASDAQ:AZN) has received FDA approval for its drug Voydeya, also known as danicopan, as an add-on therapy to Ultomiris or Soliris in the treatment of extravascular hemolysis in adults ...
This study demonstrates that danicopan significantly improves hemoglobin stability, fatigue, and overall quality of life for patients with PNH with extravascular hemolysis. In addition ...
“The extravascular, intrapericardial balloon implant requires no large vessel access, and the system avoids many of the current standard of care complications, such as major bleeding, hemolysis ...